Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Study questions link between antidepressants and hip fractures

Researchers have found that the risk of fractures in older people with depression is most elevated 16–30 days before the first antidepressant prescription is filled.

X-ray of hip joint


Study suggests that older people with depression already have an elevated risk of falls and fractures, regardless of antidepressant therapy

A previously identified link between antidepressant use and hip fractures needs further examination, the authors of a study published in JAMA Psychiatry (2 January 2019) have concluded[1].

Researchers analysed data on 204,072 people in Sweden aged 65 years and over (mean 80.1 years) who initiated antidepressant treatment between July 2006 and December 2011, matched by age and gender to an equal number of controls.

In comparison with controls, antidepressant users were more than twice as likely to experience hip fracture in both the year before (1.1% vs. 2.8%) and the year after (1.3% vs. 3.5%) therapy initiation. The risk was most elevated in the period 16–30 days before the first prescription was filled, both overall and in all subgroup analyses.

Previous research has associated antidepressant use with an increased risk of falls and fractures. However, there have been no sufficiently powered randomised trials to establish causation, the researchers explained.

They said their findings suggested that older people with depression already have an elevated risk of falls and fractures prior to antidepressant initiation, due to a high burden of comorbidity and confounding by indication.

“These findings raise questions about the association between antidepressant drug use and hip fracture that require further analysis in treatment studies.”


Citation: Clinical Pharmacist DOI: 10.1211/CP.2019.20206143

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.